On Thursday, OXiGENE Inc (NASDAQ:OXGN)’s shares declined -7.69% to $1.44.
OXiGENE Inc (OXGN) stated financial results for the quarter ended March 31, 2015.
Summary of Financial Results
At March 31, 2015, OXiGENE had cash of $36 million, contrast to $30 million at December 31, 2014. During the first quarter of 2015, the company raised gross proceeds of $10 million from a private offering of stock and warrants.
For the quarter ended March 31, 2015, OXiGENE stated a net loss of $2.8 million contrast to a net loss of $2.6 million for the comparable period in 2014. The enhance of $0.2 million in the net loss in the first quarter of 2015 as contrast to the first quarter of 2014 was due primarily to raised research and development (R&D) expenses.
R&D expenses during the first quarter of 2015 were $1.7 million contrast to $1.4 million in the first quarter of 2014. The enhance was primarily associated with costs related to the GI-NET Phase 2 trial, counting clinical research expenses and compensation costs, which were offset in part by a decrease in manufacturing costs.
OXiGENE, Inc., a biopharmaceutical company, focuses on the development of vascular disrupting agents to treat cancer in the United States. Its principal clinical stage product comprises fosbretabulin tromethamine, a reversible tubulin binding agent, which has accomplished Phase II clinical trial for treating recurrent ovarian cancer; and in Phase II clinical trial for treating gastrointestinal neuroendocrine tumors.
EZCORP Inc (NASDAQ:EZPW)’s shares dropped -7.34% to $8.33.
EZCORP Inc (EZPW) has released selected financial and operating information for the second quarter of fiscal 2015 in a Current Report on Form 8-K filed with the Securities and Exchange Commission. As formerly declared, the company delayed the filing of its Quarterly Report on Form 10-Q for the second quarter until it completes the review and analysis of certain errors identified in a portion of its Grupo Finmart loan portfolio. The Form 8-K discloses information about the second quarter that is unaffected by that review and contains more detail about the nature and scope of the Grupo Finmart review.
On May 14, 2015, the company received a written notice from The Nasdaq Stock Market stating that, due to the failure to timely file its Quarterly Report on Form 10-Q for the second quarter of fiscal 2015, the company is not presently in compliance with Nasdaq Listing Rule 5250(c)(1). The notice gives the company 60 days to submit a plan to regain compliance, and if that plan is accepted, the Nasdaq staff can grant an exception of up to 180 calendar days from the filing’s due date. The notice was predictable and has no immediate effect on the listing or trading of the company’s common stock on the Nasdaq Global Select Market. The company will submit a plan of compliance within the 60-day period, and believes that its plan will be an acceptable plan to regain compliance with the Nasdaq’s listing rules.
EZCORP, Inc. provides specialty consumer financial services. The company operates in three segments: The U.S. & Canada, Latin America, and Other International. The company offers pawn loans, which are non-recourse loans collateralized by tangible personal property, counting jewelry, consumer electronics, tools, sporting goods, and musical instruments; sells merchandise compriseing of second-hand collateral forfeited from its pawn lending activities or purchased from customers, and new or refurbished merchandise from third party vendors; and buys and sells second-hand goods.
At the end of Thursday’s trade, Ascent Solar Technologies, Inc. (NASDAQ:ASTI)‘s shares dipped -8.23% to $0.790.
Ascent Solar Technologies, Inc. (ASTI) declared an update on the Company’s 2015 year-to-date financial results.
For the first quarter, the Company stated revenue of $660K. First quarter results were negatively influenced by the typical seasonality of the consumer electronics industry, where the first quarter is typically the slowest. Q1 was also influenced by a prolonged strike at west coast ports in early 2015; this contributed to delays in product delivery for Q1, pushing back deliveries into Q2. As a result, the Company has noteworthyback-ordered bookings that should result in revenue for Q2, taking the company back on track to its earlier revenue guidance of $10M - $12M for the full year 2015.
Ascent Solar Technologies, Inc., a development stage company, designs and manufactures photovoltaic integrated consumer electronics; and portable power applications for commercial and military users.
Rexnord Corp (NYSE:RXN), ended its Thursday’s trading session with -6.49% loss, and closed at $25.37.
Rexnord Corp (RXN) Reports Fourth Quarter and Full Fiscal Year 2015 Results.
Fourth Quarter Highlights
- Net sales were $519 million.
- Diluted earnings per share from ongoing operations were $0.34.
- Adjusted earnings per share raised 8% year-over-year to $0.54.
- Accomplished Mill Products divestiture.
- Launched internal initiatives planned to deliver about $30 million of annualized savings by FY18.
Fiscal 2015 Highlights
- Net sales were $2.050 billion for fiscal year 2015.
- Adjusted EBITDA of $396 million, resulting in an adjusted EBITDA margin of 19%.
- Net income from ongoing operations was $92 million.
- Diluted earnings per share from ongoing operations was $0.88.
- Adjusted earnings per share raised 13% from the preceding year to $1.52.
- Free cash flow raised 41% from the preceding year to $203 million, or 128% of adjusted net income.
Rexnord Corporation designs, manufactures, markets, and services process and motion control, and water administration products worldwide. The company operates through two segments, Process & Motion Control Platform and Water Administration Platform
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
